Merck & Co (MRK) Q1 2020 earnings call dated April 28, 2020 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations Kenneth C.
Merck & Co (NYSE: MRK) Q1 2020 Earnings Call Transcript
Merck & Co (MRK) Q1 2020 earnings call dated April 28, 2020 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations Kenneth C.
Centene Corp (CNC) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance & Investor Relations Michael
Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter EPS
Pfizer Inc. (NYSE: PFE) Tuesday reported a decline in first-quarter earnings and revenues. However, the results exceeded analysts' forecast. Earnings, on an
Lexicon Pharmaceuticals (LXRX) Q1 2020 earnings call dated Apr. 27, 2020 Corporate Participants: Kimberly Lee -- Head of Investor Relations and Corporate Strategy Lonnel
Late last year, Biogen (NASDAQ: BIIB) made an announcement that left investors gung-ho. The stock soared 27% after the company optimistically said
Edwards Lifesciences Corp (EW) Q1 2020 earnings call dated Apr. 23, 2020 Corporate Participants: Mark Wilterding -- Vice President, Investor Relations Michael A. Mussallem -- Chairman
Eli Lilly & Co (LLY) Q1 2020 earnings call dated Apr. 23, 2020 Corporate Participants: Kevin Hern -- Vice President, Investor Relations David A.
Pharmaceutical company Eli Lilly (NYSE: LLY) reported first quarter 2020 revenue of $5.86 billion, up 15% year-over-year. Amid COVID-19 pandemic, the company
Biogen Inc (BIIB) Q1 2020 earnings call dated Apr. 22, 2020 Corporate Participants: Joe Mara -- Vice President, Investor Relations Michel Vounatsos -- Chief Executive Officer
Healthcare Services Group Inc (HCSG) Q1 2020 earnings call dated April 22, 2020 Corporate Participants: Theodore Wahl -- President & Chief Executive Officer Matthew
Quest Diagnostics Inc (DGX) Q1 2020 earnings call dated Apr. 22, 2020 Corporate Participants: Shawn Bevec -- Vice President, Investor Relations Stephen H. Rusckowski -- Chairman,
Thermo Fisher Scientific Inc (TMO) Q1 2020 earnings call dated April 22, 2020 Corporate Participants: Kenneth Apicerno -- Vice President, Investor Relations Marc N.
Quest Diagnostics Incorporated (NYSE: DGX) reported a 40% dip in earnings for the first quarter of 2020 due to lower revenue and
Global pharma giants Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) announced their earnings for Q1 2020 last week. Despite
Biogen Inc. (NASDAQ: BIIB) reported its financial results for the quarter ended March 31, 2020 today. Biogen posted a 1% decline in
Biofrontera AG (BFRA) Q4 2019 earnings call dated Apr. 21, 2020 Corporate Participants: Pamela Keck -- Investor Relations Hermann Lubbert -- Chief Executive Officer Thomas Schaffer -- Chief
Rite Aid Corporation (NYSE: RAD) recently witnessed a spurt in store traffic as people rushed to stock up on medicines amid disruptions
Intuitive Surgical Inc (ISRG) Q1 2020 earnings call dated Apr. 16, 2020 Corporate Participants: Calvin Darling -- Senior Director, Finance, Investor Relations Gary S.
Intuitive Surgical Inc. (NASDAQ: ISRG) reported higher earnings and revenues for the first quarter of 2020. The results also topped the Street
Abbott Laboratories (ABT) Q1 2020 earnings call dated Apr. 16, 2020 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and Acquisitions